Skip to main content
. 2017 Jul 21;19(7):e264. doi: 10.2196/jmir.6743

Table 5.

Comparison of quality of life between the two groups before and after intervention.

Item and group Baseline After intervention (month) F1,4 P


1 3 6 12

Total







Intervention, mean (SD) 47.20 (18.73) 37.95 (20.89)a 35.02 (20.42)a 34.45 (19.95)a 31.35 (20.53)a,b 20.364 <.001

Control, mean (SD) 51.22 (18.53) 47.95 (19.60) 51.03 (21.46)b 55.69 (20.90)a,b,c 57.92 (21.41)a,b,c,d 10.001 <.001

t1 –1.177 –2.705 –4.163 –5.663 –6.904


P .24 .01 <.001 <.001 <.001

Symptom







Intervention, mean (SD) 61.87 (19.75) 41.04 (27.30)a 38.56 (24.71)a 38.84 (23.60)a 35.82 (21.32)a 16.194 <.001

Control, mean (SD) 57.74 (19.77) 47.95 (19.60)a 49.95 (25.85)a 54.98 (23.48)b,c 58.03 (23.71)b,c 5.905 <.001

t1 1.142 –1.355 –2.454 –3.745 –5.353


P .26 .18 .02 <.001 <.001

Activity







Intervention, mean (SD) 58.24 (23.16) 51.09 (24.38)a 50.13 (24.89)a 47.15 (25.43)a 43.96 (24.66)a,b 7.101 <.001

Control, mean (SD) 65.49 (20.19) 64.58 (21.37) 65.02 (23.27) 68.77 (22.19) 69.00 (22.45) 1.996 .12

t1 –1.834 –3.231 –3.382 –4.974 –5.818


P .07 .002 .001 <.001 <.001

Impacts







Intervention, mean (SD) 34.85 (21.01) 29.18 (20.31)a 26.00 (20.93)a 26.80 (21.04)a 22.89 (22.12)a 3.279 .02

Control, mean (SD) 40.42 (20.10) 37.48 (20.97) 41.02 (22.43)b 44.49 (22.06)b 48.48 (22.88)a,b,c,d 7.851 <.001

t1 –1.479 –2.191 –3.767 –4.470 –6.198


P .14 .03 <.001 <.001 <.001

a Significant compared to baseline.

b Significant compared to 1 month.

c Significant compared to 3 months.

d Significant compared to 6 months.